Navigation Links
Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
Date:5/10/2013

NEW YORK, May 10, 2013 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a securities class action has been commenced in the United States District Court for the District of Massachusetts on behalf of a class (the "Class") of purchasers of Aveo Pharmaceutical, Inc. ("Aveo" or the "Company") (NASDAQ: AVEO) securities between January 3, 2012 and May 1, 2013 (the "Class Period").

Aveo is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapies.  The Company's lead product is an oral inhibitor of the vascular endothelial growth factor ("VEGF") receptors.

The Complaint alleges that throughout the Class Period, Defendants conditioned investors to believe that the Company's drug Tivopath (or Tivozanib) would receive approval from the U.S. Food and Drug Administration ("FDA") through a host of materially false and misleading statements regarding its Phase III ("TIVO-1") trial design and results.  Specifically, the Company (a) failed to disclose to investors that the FDA had recommended that the Company conduct an additional Phase III trial due to adverse trends in the Company's first study; (b) misled investors regarding the overall safety and efficacy of the product, including failing to disclose the 25% higher rate of death associated with Tivozanib therapy compared to the control drug, Sorafenib; and (c) failed to disclose that almost 90% of the patients studied in TIVO-1 were enrolled from sites in Central and Eastern Europe with inconsistent treatment patterns from those in the U.S.  As a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

On April 30, 2013, the FDA released its Oncologic Drugs Advisory Committee ("ODAC")
'/>"/>

SOURCE Bernstein Liebhard LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
2. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
3. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... FRANCISCO , July 1, 2015  goBalto, ... startup solutions, announced today unprecedented growth in serving ... is intense pressure to speed clinical trials and ... globalization, and paper-based methods have stalled these efforts," ... current status of clinical trials has encouraged Industry ...
(Date:7/1/2015)... Prismic Pharmaceuticals, Inc., a specialty pharmaceutical company ... announced the election of Joseph J. Krivulka ... of Directors. Commenting on the election of ... Chairman and CEO of Prismic, stated, "We are delighted ... have accepted our invitation to join Prismic,s Board ...
(Date:7/1/2015)... DIEGO , July 1, 2015  Imprimis ... company focused on the development and commercialization of ... company will ring The Nasdaq stock market closing ... celebrating the growing success of its Go Dropless™ ... 3.6 million cataract procedures are performed annually in ...
Breaking Medicine Technology:goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... 14 Medizone International, Inc. (OTC Bulletin ... AsepticSure(TM) trials have begun at Innovation Park, Queen,s University. ... and second round of laboratory testing, this third round ... in order to obtain maximum bactericidal action in combination ...
... , TROY, Mich., Oct. 14 Somanetics Corporation (Nasdaq: ... an Exclusive Sublicense Agreement with Raba Equity Partners II, ... Somanetics has obtained exclusive rights, subject to specified rights ... Johns Hopkins University, to new cerebral autoregulation technology developed ...
Cached Medicine Technology:Medizone International Announces Third Round of AsepticSure 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5
(Date:7/2/2015)... Beach, FL (PRWEB) , ... July 02, 2015 , ... ... information and entertainment differently, but also how they interact with products in their everyday ... everything from appliances and security systems to home entertainment and safety, as well as ...
(Date:7/2/2015)... ... ... an effect on the body. And during the hot summer season, fitness guru Iryna Lobur ... of the right foods, as well as drinking plenty of water. , But on the ... front as well, with sweet treats like ice cream and snow cones more popular than ever ...
(Date:7/2/2015)... ... July 02, 2015 , ... Patton State Hospital ... State Hospitals. Prior to using Winscribe’s dictation and clinical documentation solutions, Patton State ... manage their organization’s dictation and transcription processes. , Over the years, ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... their products, services, channels and business models. To help manage the increasing demand ... addition of Mark Benkendorf as SVP of Strategic Engagements. , Benkendorf is a ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... sponsorship complete, St. Joseph’s Health, located in Syracuse, N.Y., is now a member ... we have gained an admirable and important partner committed to delivering high-value care, ...
Breaking Medicine News(10 mins):Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 3Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4
... be pleased with a new study suggesting music lessons help ... at the Chinese University of Hong Kong, indicates children with ... without training. ,Researchers put 135 boys between ages 6 ... had to recall words from a list and perform a ...
... study shows anemia may double the risk of an ... the ability to live independently. Researchers say seniors who ... just above the traditional cut-off point for the condition's ... than those who have normal blood hemoglobin levels.// ...
... of intraocular fluid into the venous system, wearing a ... to a report published in the August issue of ... that wearing a tight necktie produces a significant rise ... Although it could take several years of tie wearing ...
... make people more susceptible to depression after stressful events, such ... have to inherit one copy of the gene, from either ... Britain, New Zealand and the United States found. ,Stress events, ... of the five leading causes of disability in the world. ...
... exams can make you break out. There are a lot ... clinical studies have looked at this, Dr. Alexa B. Kimball, ... study with the goal of debunking this myth," she added. ... clearly that acne causes stress," Kimball noted. But when she ...
... claim eating pizza regularly reduced the risk of developing throat ... also fell by 26 percent and mouth cancer by 34 ... developed cancer of the mouth, esophagus, throat or colon and ... Those who ate pizza at least once a week had ...
Cached Medicine News:
... is winning the hearts of cardiologists and ... are the operative words for Heartline™. Patients ... time they and their attending physician know ... in their heart condition is only a ...
... Implant is 40% thinner than our ... thickness provides improved eyelid cosmesis while ... proven Contour implant. Our ThinProfile ... curvature and precise tapering to produce ...
... IOPac give you corrected IOP measurements in the ... importance of CCT. Make your IOP readings ... glaucoma pachymeter with built-in IOP calculations. ... professional, it provides accurate corneal measurements in a ...
Use the Oculus Mesotest II before and after IOL or refractive surgery. Selectable Landolt ring positions. Accurate measurements in four contrast levels, with and without glare, independent of the pup...
Medicine Products: